IP Library Granted Patent US 8,389,467
Granted Patent B2
US 8,389,467 · App. 12/575,765 · Granted Mar 5, 2013

In situ self-setting mineral-polymer hybrid materials, composition and use thereof

Inventors: Cyril Chaput (Montreal, CA); Anabelle Rodrigues El Zein (Montreal-Nord, CA)
Assignee: Piramal Healthcare (Canada) Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,389,467
App. No.
12/575,765
Granted
Mar 5, 2013
Kind
B2
Abstract

The present invention relates to self-setting compositions consisting in admixed liquid and solid components enable the formation of hardened bio-materials having a broad range of properties and performances. The present invention proposes a) a thermo-sensitive self-gelling liquid component, being water-based, comprising at least a polycationic and a phosphate source, wherein the liquid component is a thermo-gelling solution at a pH ranging from 6.5 to 7.4; b) a powder component consisting in at least two calcium phosphate sources. The preferred calcium phosphate source includes apatites, tricalcium phosphates, tetracalcium phosphates and dicalcium phosphates. Both solid and liquid components are admixed to form a flowable slurry that sets in situ into a hardened calcium phosphate based bio-material.

Claims (13)

1. An injectable self-setting composition comprising:

a) a liquid component, free of insoluble material, comprising, an organic and/or inorganic acid, a partially N-deacetylated chitosan and/or a collagen, and a glycerophosphate salt; said liquid component having a pH ranging from 6.5 to 7.4, said liquid component having an endothermally gelling character, said partially N-deacetylated chitosan having a final concentration ranging between 0.5 to 3.0% w/v, and said glycerophosphate salt having a final concentration ranging between 1.0 to 10.0% w/v, and

b) a powder component comprising a dry mixture of a tricalcium phosphate with a calcium deficient apatite or an octacalcium phosphate, and with at least one of an inorganic salt, an organic salt, an organic acid source and an organic compound,

wherein when said components of step a) and b) are intimately and uniformly mixed together, said components of step a) and b) form an injectable thermo-setting slurry, said slurry when heated turns into a solid material.

2. The composition as described in claim 1 , wherein said inorganic salt is selected from carbonate, phosphate, strontium, and fluoride salts.

3. The composition as described in claim 1 , wherein said organic salt is selected from citrate, malate, lactate, and gluconate salts.

4. The composition as described in claim 1 , wherein said organic acid is selected from citric acid, malic acid, lactic acid, and gluconic acid.

5. The composition as described in claim 1 , wherein said organic compound is selected from the group consisting of biological fluids and components, water-soluble or miscible organic polyols, drugs, aminoacids, and proteins.

6. The composition as described in claim 1 , which further comprises a water-soluble or miscible organic polyol, including sugar-polyol, saccharide-polyol and glycol, selected from the group consisting of glycerol, mannitol, sorbitol, ethylene glycol oligomers, propylene glycol oligomers, saccharose, fructose, glucose, and maltose.

7. The composition as described in claim 1 , which further comprises glucosamine and/or histidine.

8. The composition as described in claim 1 , which further comprises a strontium containing compound.

9. The composition as described in claim 1 , which further comprises a carbonate containing compound.

10. The composition as described in claim 1 , which further comprises a fluoride containing compound.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2016
From: PIRAMAL HEALTHCARE (CANADA) LIMITED
To: SMITH & NEPHEW ORTHOPAEDICS AG
Reel/Frame 039937/0787 →
SECURITY AGREEMENT Recorded Sep 16, 2013
From: PIRAMAL HEALTHCARE (CANADA) LIMITED
To: HSBC BANK CANADA
Reel/Frame 031217/0431 →
ASSET PURCHASE AGREEMENT Recorded Oct 26, 2010
From: BIO SYNTECH CANADA INC.; BIOSYNTECH, INC.
To: PIRAMAL HEALTHCARE (CANADA) LTD.
Reel/Frame 025192/0144 →
Continuity (3)
Continuation 10149052
Provisional Application 60169954 · Dec 9, 1999
Related Publication 20100029549A1 · Feb 4, 2010